2/12/2013

SPECT imaging with 99mTc-labeled iminodiacetic acid before and during radiation therapy to monitor hepatic function in patients with unresectable liver cancer provides data that could allow for more personalized treatment plans, according to a study presented at an imaging and radiation therapy conference. "The physiological adaptation of radiation therapy based upon individual response assessment is a valuable new paradigm worth additional testing," said lead researcher Hesheng Wang of the University of Michigan.

Full Story:
MedicalXpress.com

Related Summaries